Prohost Biotech - Exclusive Biotech Research - A Comprehensive Resource for Biotech News

Travere Therapeutics: Positive Trial Results of its Product Sparsentan in Treating IgA Nephropathy

August 16, 2021 0

Travere Therapeutics Sparsentan for IgAN Positive Results Phase 3 PROTECT Study of Travere Therapeutics (TVTX) product sparsentan …

Akero Therapeutics Inc Q2 Business Updates and Financial Results

August 13, 2021 0

Akero Therapeutics Inc Akero Therapeutics Inc (AKRO) is a clinical-stage cardio-metabolic company developing transformational treatments for …

A Biotechnology Company to Remember and Appreciate

August 12, 2021 0

Vir Biotechnology: What We've Learned from Dr. George Scangos George Scangos, PhD. is the chief executive …

Reata Pharmaceuticals Two Stories: Updated News of its Clinical Programs and Finances

August 11, 2021 0

Reata Pharmaceuticals Two Stories Omaveloxolone in Patients with Friedreich’s Ataxia Several communications between Reata Pharmaceuticals (RETA) …

Agenus Inc Corporate Update and Financial Results for Q2 2021. See Also: Why Intellia Was Down Today

August 9, 2021 0

Agenus Inc News and Q2 Results for 201 Agenus (AGEN) announced results with better than usual …

A Reevaluation of Prohost Biotech’s Picked Firms

August 9, 2021 0

Prohost Letter #446 A Reevaluation of Prohost Biotech’s Picked Firms We have already pinpointed some of …

The U.S. FDA Accepts Exelixis sNDA of CABOMETYX® for Priority Review

August 6, 2021 0

Exelixis sNDA Accepted by the US FDA for CABOMETYX® The U.S. Food and Drug Administration (FDA) …

Novartis Announces Lift of Partial Clinical Trial Hold. See Also: Plans to Initiate a New SMA Study

August 4, 2021 0

Novartis Partial Clinical Trial Hold for OAV-101 IT for SMA Lifted Novartis (NVS) announced that the …

Sanofi to Acquire Translate Bio, Advancing mRNA Technology. See Also: Cassava Science Q2 Financial Results

August 3, 2021 0

Sanofi Will Acquire Translate Bio Sanofi (SNY) will acquire all the outstanding shares of Translate Bio (

AstraZeneca: Big Step Towards Improving the Lives of SLE Patients and More on Cassava Sciences

August 2, 2021 0

Cassava Sciences There is no doubt in our minds that Cassava Sciences’ (SAVA) product simufilam will …

Cassava Sciences Good News and an Unwarranted Sell-Off. A New Drug Approval for Bristol-Myers Squibb and ImmunoGen Quarterly Results

July 30, 2021 0

Cassava Sciences Inc Following Cassava Sciences Inc successful and promising presentations, all the titles of the …

Cassava Sciences Inc: Today’s Press Releases

July 29, 2021 0

Cassava Sciences Inc Press Release Related to Positive Biomarker Data Cassava Sciences Inc (SAVA) announced today, …

GlaxoSmithKline and Vir Biotechnology Announce Joint Procurement Agreement with the EC for COVID-19 Treatment

July 28, 2021 0

GlaxoSmithKline and Vir Biotechnology Signed a Joint Procurement Agreement with the EC GlaxoSmithKline (GSK) and Vir Biotechnology …

Cassava Sciences Announces Positive Data with SavaDx from a Randomized Controlled Phase 2b Study of Simufilam

July 26, 2021 0

Cassava Sciences: Positive Clinical Data with SavaDX Cassava Sciences (SAVA) today announced positive clinical data with SavaDx, …

bluebird bio Receives Approval for its Gene Therapy SKYSONA™ for Young People with Early CALD Without a Matched Sibling Donor

July 22, 2021 0

bluebird bio Receives EC Approval for bluebird bio (BLUE) announced that the European Commission (EC) has granted marketing authorization …

Exclusive Market Insight

& Scientific analysis

Latest Articlesddd

Travere Therapeutics: Positive Trial Results of its Product Sparsentan in Treating IgA Nephropathy

Akero Therapeutics Inc Q2 Business Updates and Financial Results

A Biotechnology Company to Remember and Appreciate

Reata Pharmaceuticals Two Stories: Updated News of its Clinical Programs and Finances

Agenus Inc Corporate Update and Financial Results for Q2 2021. See Also: Why Intellia Was Down Today

A Reevaluation of Prohost Biotech’s Picked Firms

The U.S. FDA Accepts Exelixis sNDA of CABOMETYX® for Priority Review

Novartis Announces Lift of Partial Clinical Trial Hold. See Also: Plans to Initiate a New SMA Study

Sanofi to Acquire Translate Bio, Advancing mRNA Technology. See Also: Cassava Science Q2 Financial Results

AstraZeneca: Big Step Towards Improving the Lives of SLE Patients and More on Cassava Sciences

Cassava Sciences Good News and an Unwarranted Sell-Off. A New Drug Approval for Bristol-Myers Squibb and ImmunoGen Quarterly Results

Cassava Sciences Inc: Today’s Press Releases

GlaxoSmithKline and Vir Biotechnology Announce Joint Procurement Agreement with the EC for COVID-19 Treatment

Cassava Sciences Announces Positive Data with SavaDx from a Randomized Controlled Phase 2b Study of Simufilam

bluebird bio Receives Approval for its Gene Therapy SKYSONA™ for Young People with Early CALD Without a Matched Sibling Donor

Cassava Sciences Stock Soared. See Also: The Resurrection of Sunesis Pharmaceuticals

Immunome Inc Stock Rallied After Announcing it Neutralized the SARS-CoV-2 Delta Variant.

Why Cytokinetics’ Stock Price Soared in a Bad Market Day

Important Steps Forward Taken by Vir Biotechnology and Separately by Compugen

Encouraging News from Hoth Therapeutics and Kintor Pharmaceutical Ltd About Treating Acne and Alopecia